Effects of successful treatment of cough on health status Source: Annual Congress 2003 - Cough and sleep disorders Year: 2003
Effects of CXCR2 antagonists on neutrophil chemotaxis from COPD patients Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010
Effects of nutritional status on dyspnea in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 253s Year: 2002
Effect of long-acting muscarinic antagonist (LAMA) on 24-hour physical behaviours in COPD Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation Year: 2020
Effects of integrated care on lung function and health status in COPD patients Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
The effect of leukotrienes receptor antagonists on lung function, exercise tolerance and incidence of exacerbations in patients with stable, moderate COPD Source: Eur Respir J 2002; 20: Suppl. 38, 620s Year: 2002
Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma Source: Eur Respir J 2007; 29: 502-508 Year: 2007
Safety and efficacy of SCH527123, a novel CXCR2 antagonist, in patients with COPD Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease Year: 2010
Assessing health status in COPD Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013
Additional overall benefit to coexistent asthma and rhinitis symptoms control in patients treated with leukotriene receptor antagonist Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
Effects of tiotropium on systemic inflammation and nutrition status Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases Year: 2008
Influence of gender on health status response to long-term oxygen therapy in very severe COPD patients Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients Year: 2009
Predictors of health status in COPD patients Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008
Effect of angiotensin II receptor antagonists on cardiovascular disorders in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 212s Year: 2001
Salmeterol response is not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 505s Year: 2005
Rates of asthma exacerbations are not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 708s Year: 2005
Effect of AVE5883, a dual NK1/NK2 receptor antagonist, on airway responsiveness to neurokinin A in asthma Source: Eur Respir J 2004; 24: Suppl. 48, 219s Year: 2004
Effects of self-management action plans for COPD patients with comorbidities on health status and self-efficacy Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017
Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006